Transforming growth factor (TGFβ) is a multifunctional cytokine with proinflammatory as well as immunosuppressive activities. A regulatory role for TGFβ has been suggested in investigations of several experimental and spontaneous models of pathological autoreactivity. It is suggested that many of the functional effects of TGFβ parallel the major immune system abnormalities seen in SLE.
Roberts AB, Anzano MA, Wakefield LM et al. Type B transforming growth factor: a bifunctional regulator of cellular growth. Proc Natl Acad Sci USA1985; 82: 119-23.
2.
Sporn MB, Roberts AB, Wakefield LM et al. Some recent advances in the chemistry and biology of transforming growth factor-beta. J Cell Biol1987; 105: 1039-45.
3.
Lyons RM, Moses HLReview: transforming growth factors and the regulation of cell proliferation . Eur J Biochem1990; 187: 467-73.,
Wahl SM, McCartney-Francis N, Mergenhagen SE. Inflammatory and immunomodulatory roles of TGFβ. Immunology Today1989; 10: 258-61.
6.
Wahl SMTransforming growth factor beta in inflammation: a cause and a cure . J Clin Immunol1992; 12: 61-73.
7.
Daopin S., Piez KA, Agawa Y. et al. Crystal structure of transforming growth factor-β2: an unusual fold for the superfamily. Science1993: 257: 369-73.
8.
Schlunegger MP , Grutter MGAn unusual feature revealed by the crystal structure at 2.2 Å resolution of human transforming growth factor-β2 . Nature1992; 358: 430-4.
9.
Assoian RK, Sporn MBType B transforming growth factor in human platelets: release during platelet degranulation and action of vascular smooth muscle cells. J Cell Biol1986; 102: 1217-23.
Kehrl JH, Wakefield UM, Roberts AB et al. Production of transforming growth factor B by human lymphocytes and its potential role in the regulation of T cell growth. J Exp Med1986; 163: 1037-50.
12.
Kehrl JH, Roberts AB, Wakefield LM et al. Transforming growth factor B is an important immunomodulatory protein for human B lymphocytes. J Immunol1986; 137: 3855-60.
13.
Assoian RK, Fleurdelys BE, Stevenson HC et al. Expression and secretion of type B transforming growth factor by activated human macrophages. Proc Natl Acad Sci USA1987; 84: 6020-4.
14.
Gelb DE, Rosier RN, Puzas JEThe production of transforming growth factor B by chick growth plate chondrocytes in short-term monolayer culture. Endocrinology1990; 127: 1941-7.
15.
Bascom CC, Wolfshohl JR, Coffey RJ et al. Complex regulation of transforming growth factor beta 1, beta 2 and beta 3 mRNA expression in mouse fibroblasts and keratinocytes by transforming growth factor beta 1 and beta 2. Mol Cell Biol1989; 9: 5508-15.
16.
Glick AB, Flanders KC, Danielpour D. et al. Retinoic acid induces transforming growth factor β2 in cultured keratinocytes and mouse epidermis. Cell Regulation1989; 1: 87-97.
17.
Constam DB, Philipp J., Malipiero UV et al. Differential expression of transforming growth factor β1, β2 and β3 by glioblastoma cells, astrocytes and microglia. J Immunol1992; 148: 1404-10.
18.
Roberts AB, Sporn MBTransforming growth factor β. Adv Cancer Res1988; 51: 107-45.
19.
Wakefield LM , Sporn MBSuppression of carcinogenesis: a role for TGFβ and related molecules in prevention of cancer. Immunol Ser1990; 51: 217-43.
20.
Bodoner SK, Strommer K., Frei C. et al. Immunosuppression and transforming growth factor β in glioblastoma: preferential production of transforming growth factor β2. J Immunol1990; 143: 3222-8.
21.
Kim SJ, Kehrl JH, Burton J. et al. Transactivation of the transforming growth factor β1 gene by human T lymphotropic virus type 1 tax: a potential mechanism for the increased production of TGFβ1 in adult T cell leukemia. J Exp Med1990; 172: 121-9.
22.
Kim SJ, Bogdan NJ, D'Agostano LJ et al. Effect of topical retinoic acids on the levels of collagen mRNA during the repair of UVB-induced dermal damage in the hairless mouse and the possible role of TGFβ as a mediator. J Invest Dermatol1992; 98: 359-63.
23.
Wahl SM, Allen JB, McCartney-Francis N. et al. Macrophage- and astrocyte-derived transforming growth factor β as a mediator of central nervous system dysfunction in acquired immune deficiency syndrome. J Exp Med1991; 173: 981-91.
24.
Massague J.Receptors for the TGFβ family. Cell1992; 69: 1067-70.
25.
Wahl SM, Hunt DA, Wakefield L. et al. Transforming growth factor beta (TOFβ) induces monocyte chemotaxis and growth factor production. Proc Natl Acad Sci USA1987; 84: 5788-92.
26.
Adams DH, Hathaway M., Shaw J. et al. Transforming growth factor β induces human T lymphocyte migration in vitro. J Immunol1991; 147: 609-17.
27.
Chantry D., Turner M., Abnney E. et al. Modulation of cytokine production by transforming growth factor β . J Immunol1989; 142: 4295-300.
28.
Springer TAAdhesion receptors of the immune system. Nature1990; 346: 425-34.
Ignotz R., Heino J., Massague J.Regulation of cell adhesion receptors by transforming growth factor β: regulation of fibronectin receptor and LFA-1. J Biol Chem1989; 264: 389.
31.
Welch G., Wong H., Wahl SMSelective induction of FCγRIII on human monocytes by transforming growth factor β. J Immunol1990; 144: 3444-8.
32.
Brandes ME, Allen JB, Agawa Y. et al. TGFβ1 suppress leukocyte recruitment and synovial inflammation in experimental arthritis. J Clin Invest1991 ; 87: 1108-13.
33.
Gresham HD, Ray CJ, O'Sullivan FX. Defective neutrophil function in the autoimmune mouse strain MRL/1pr: a potential role of transforming growth factor β1. J Immunol1991; 146: 3911-21.
34.
Ristow HJBSC-1 growth inhibitor/type β transforming growth factor is a strong inhibitor of thymocyte proliferation. Proc Natl Acad Sci USA1986; 83: 5531-3.
35.
Kehrl JH, Wakefield LM, Roberts AB et al. Production of transforming growth factor β by human T lymphocytes and its potential role in the regulation of T cell growth. J Exp Med1986; 163: 1037-50.
36.
Wahl SM, Hunt DA, Wong HL et al. Transforming growth factor βis a potent immunosuppressive agent that inhibits IL-2 dependent lymphocyte proliferation. J Immunol1988; 140: 3026-32.
37.
Dubois CM, Ruscetti FW, Palaszynski EN et al. Transforming growth factor β is a potent inhibitor of interleukin (IL-1) receptor expression: proposed mechanism of inhibition of IL-1 action . J Exp Med1990; 172: 737-44.
38.
Wahl SM, Costa GL, Corcoran M. et al. Transforming growth factor β mediates IL-1 dependent induction of IL-1 receptor antagonist. J Immunol1993 ; 150: 3553-60.
39.
Brabletz T. , Pfeuffer I., Schorr E. et al. Transforming growth factor β and cyclosporin A inhibit the inducible activity of the interleukin-2 gene in T cells through a non-canonical octomer-binding site . Mol Cell Biol1993; 13: 1155-62.
40.
Pietenpol JA , Holt JT, Stein RW et al. Transforming growth factor β1 suppression of c-myc gene transcription: role in inhibition of keratinocyte production . Proc Natl Acad Sci USA1990; 87: 3758-62.
41.
Tada T., Ohzeki S., Utsumi K. et al. Transforming growth factor β-induced inhibition ofT cell function: susceptibility difference in T cells of various phenotypes and functions and its relevance to immunosuppression in the tumor-bearing state. J Immunol1991; 146: 1077-82.
42.
Espevik T., Figari IS, Shalaby MF et al. Inhibition of cytokine production by cyclosporin A and transforming growth factor β. J Exp Med1987; 166: 571-6.
43.
Barral-Netto M., Barral A., Brownell C. et al. Transforming growth factor β in Leishmanial infection: a parasite escape mechanism . Science1992; 257: 545-8.
44.
Kehrl JH, Roberts AB, Wakefield LM et al. Transforming growth factor β is an important immunomodulatory protein for human β lymphocytes. J Immunol1986; 137: 3855-60.
45.
Kehrl JH, Thevenin C., Rieckmann P. et al. Transforming growth factor β suppresses human B lymphocyte Ig production by inhibiting synthesis and the switch from the membrane form to the secreted form of Ig mRNA. J Immunol1991; 146: 4016-23.
46.
Ninomiya C. , Spiegelberg HLIL-4 and transforming growth factor β suppress human immunoglobulin secretion in vitro by surface IgD-B cells. Clin Exp Immunol1992; 89: 261-8.
47.
Kim PH, Kagnoff MFTransforming growth factor β1 increases IgA isotype switching at the clonal level. J Immunol1990; 145: 3773-8.
48.
Ehrharat RO , Strober W., Hariman GREffect of transforming growth factor (TGF)-β1 on IgA isotype expression. TGF-β1 induces a small increase in sIgA + B cells regardless of the method of B cell activation . J Immunol1992; 148: 3830-6.
49.
Defrance T. , Vanbervliet B., Briere F. et al. Interleukin-10 and transforming growth factor β cooperate to induce anti-CD40-activated naive human B cells to secrete immunoglobulin A. J Exp Med1992; 175: 671-82.
50.
Berg DJ, Lynch RGImmune dysfunction in mice with plasmacytomas. I. Evidence that transforming growth factor β contributes to the altered expression of activation receptors in host B lymphocytes. J Immunol1991; 146: 2865-72.
51.
Ranges GE, Figdir IS, Espevik T. et al. Inhibition of cytotoxic T cell development by transforming growth factor β and reversal by recombinant tumor necrosis factor α. J Exp Med1987; 166: 991-8.
52.
Kasid A., Bell GI, Director EPEffects of transforming growth factor β on human lymphokine-activated killer cell precursors. J Immunol1988 ; 141: 690-8.
53.
Su HC, Leite-Morris KA, Braun L. et al. A role for transforming growth factor β1 in regulating natural killer cell and T lymphocyte proliferative responses during acute infection with lymphocytic choriomeningitis virus. J Immunol1991; 147: 2717-27.
54.
Tsunawaki S. , Sporn M., Ding A. et al. Deactivation of macrophages by transforming growth factor β . Nature1988; 334: 260-4.
55.
Bermudez LEProduction of transforming growth factor β by Mycobacterium avium-infected human macrophages is associated with unresponsiveness to IFN-γ. J Immunol1993; 150: 1838-45.
56.
Roberts AB, Sporn MB, Assoian RK et al. Transforming growth factor β: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc Natl Acad Sci USA1986; 83: 4167-71.
57.
Leof EB, Proper JA, Goustin AS et al. Induction of c-sis mRNA and platelet-derived growth factor-like activity by transforming growth factor type β: a proposed model for indirect mitogenesis is involving autocrine activity. Proc Natl Acad Sci USA1986; 83: 2453-57.
58.
Ishikawa O. , LeRoy EC, Trojanowska M.Mitogenic effect of transforming growth factor β on human fibroblasts involves the induction of platelet-derived growth factor αreceptors . J Cell Physiol1990; 145: 181-6.
59.
Edwards DR, Murphy G., Reynolds JJ et al. Transforming growth factor beta modulates the expression of collagenase and metalloproteinase inhibitor. EMBO J1987; 6: 1899-904.
60.
Ignotz RA, Endo T., Massague J.Regulation of fibronectin and type 1 collagen mRNA levels by transforming growth factor β. J Biol Chem1987; 262: 6443-6.
61.
Skull MM, Ormsby I., Kier AB et al. Targeted disruption of the mouse transforming growth factor β1 gene results in multifocal inflammatory disease. Nature1992; 359: 693-9.
62.
Kulkami A., Huh C-G., Becker D. et al. Transforming growth factor β1 null mutation in mice causes excessive inflammatory response and early death. Proc Natl Acad Sci USA1993; 90: 770-4.
63.
Border WA, Okuda S., Languino LR et al. Suppression of experimental glomerulonephritis by antiserum against transforming growth factor β1. Nature1990; 346: 371-4.
64.
Border WA, Ruoslahti E.Transforming growth factor β in disease: the dark side of tissue repair . J Clin Invest1992; 90: 1-7.
65.
Border WA, Noble NA, Yamamoto T. et al. Natural inhibitor of transforming growth factor β protects against scarring in experimental kidney disease. Nature1992; 360: 361-4.
66.
Kuruvilla AP , Shah R., Hochwald GM et al. Protective effect of transforming growth factor β1 on experimental autoimmune diseases in mice. Proc Natl Acad Sci USA1991; 88: 2918-21.
67.
Cooper WO, Fava RA, Gates CA et al. Acceleration of onset of collagen-induced arthritis by intra-articular injection of tumor necrosis factor or transforming growth factor-beta. Clin Exp Immunol1992; 89: 244-50.
68.
Rache MK, Dhib-Jalbut S., Cannella B. et al. Prevention and treatment of chronic relapsing experimental allergic encephalomyelitis by transforming growth factor β. J Immunol1991; 146: 3012-17.
69.
John LD, Flanders KC, Ranges GE et al. Successful treatment of experimental allergic encephalomyelitis with transforming growth factor β1. J Immunol1991; 147: 1792-6.
70.
Raz E., Watanabe A., Eisenberg RA, Carson DACytokine gene therapy for murine lupus. Arthritis Rheum1992; 35 (Suppl.): S51.
71.
Kekow J., Wachsman W., McCutchan JA et al. Transforming growth factor β and noncytopathic mechanisms of immunodeficiency in HIV infection. Proc Natl Acad Sci USA1990; 87: 8321-5.
72.
Kekow J., Wachsman W., McCutchan JA et al. Transforming growth factor β and suppression of humoral immune responses in HIV infection. J Clin Invest1991; 87: 1010-16.
73.
Lafyatis R. , Thompson NL, Remmers EF et al. Transforming growth factor β production by synovial tissues from rheumatoid patients and streptococcal cell wall arthritic rats. Studies on secretion by synovial fibroblast-like cells and immunohistologic localization. J Immunol1989; 143: 1142-8.
74.
Wahl SM, Allen JB, Welch GR, Wong HLTransforming growth factor β in synovial fluids modulates FcγRIII (CD16) expression on mononuclear phagocytes. J Immunol1992; 148: 485-90.
75.
Lotz M., Kekow J., Carson DATransforming growth factor β and cellular immune responses in synovial fluid. J Immunol1990; 144: 4189-94.
76.
LeRoy ECSystemic sclerosis (scleroderma). In: Wyngaarden JB, Smith LH, eds. Cecil Textbook of Medicine. Philadelphia: WB Saunders, 1988: 2018-24.
77.
Kulozik M., Hogg A., Lankat-Buttgereit B. et al. Co-localization of transforming growth factor β2 with α1 (I) procollagen mRNA in tissue sections of patients with systemic sclerosis . J Clin Invest1990; 86: 917-22.
78.
LeRoy EC, Smith EA, Kahaleh MB et al. A strategy for scleroderma (systemic sclerosis): is transforming growth factor beta the answer?Arthritis Rheum1989; 32: 817-25.
79.
Kikuchi K., Yamakage A., Smith EA et al. Differential modulation of bFGF receptors by TGFβ in adult skin, scleroderma skin and newborn foreskin fibroblasts. J Invest Dermatol1992; 99: 201-5.
80.
Yamakage A. , Kikuchi K., Smith EASelective upregulation of platelet-derived growth factor a receptors by transforming growth factor β in scleroderma fibroblasts. J Exp Med1992 ; 175: 1227-34.
81.
Keystone EC , Lok C., Appleton B. et al. Elevated serum levels of transforming growth factor β in patients with scleroderma. Arthritis Rheum1992; 35(S): S206.
82.
Khalil N., O'Connor RN, Unruh HW et al. Increased production and immunohistochemical localization of transforming growth factor β in idiopathic pulmonary fibrosis. Am J Respir Cell Mol Biol1991; 5: 155-62.
83.
Broekelmann TJ, Limper AH, Colby TV, McDonald JATransforming growth factor β1 is present at sites of extracellular matrix gene expression in human pulmonary fibrosis . Proc Natl Acad Sci USA1991; 88: 6642-6.
84.
Phan SH, Gharaee-Kermani M., Wolber F., Ryan U.Stimulation of rat endothelial cell transforming growth factor β production by bleomycin. J Clin Invest1991; 87: 148-54.
85.
Breen E., Skull S., Bume S. et al. Bleomycin regulation of transforming growth factor β mRNA in rat lung fibroblasts. Am J Respir Cell Mol Biol1992; 6: 146-52.
86.
Zugmaier G. , Pai KS et al. Transforming growth factor β1 induces cachexia and systemic fibrosis without an anti-tumor effect in nude mice. Cancer Res1991; 51: 3590-4.
87.
Czaja MJ, Weiner FR, Flandas KC et al. In vitro and in vivo association of transforming growth factor β 1 with hepatic fibrosis. J Cell Biol1989; 108: 2477-82.
88.
Nakatsukasa H., Nagy P., Everts RP et al. Cellular distribution of transforming growth factor β1 and procollagen types I, III and IV transcripts in carbon tetrachloride-induced rat liver fibrosis. J Clin Invest1990; 85: 1833-43.
89.
Castillo A. , Prieto J., Fausto N.Transforming growth factors β1 and α in chronic liver disease: effects of interferon alpha therapy. New Engl J Med1991; 14: 933-40.
90.
Steinberg AD , Gourley MF, Klinman DM et al. Systemic lupus erythematosus. Ann Intern Med1991; 115: 548-59.
91.
Tsokos GCOverview of cellular immune function in systemic lupus erythematosus . In: Lahita RG, ed. Systemic Lupus Erythematosus, 2nd edn. New York : Churchill Livingstone, 1992: 15-50.
92.
DelGiudice G., Elkon KB, Crow MK Augmented T cell response to recall antigens by anti-TGFβ antibody in patients with SLE. Arthritis Rheum1992; 35: S225.
